UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Rapid decline of fasting glucose in HCV diabetic patients treated with direct-acting antiviral agents

Clinical microbiology and infection, 2016-05, Vol.22 (5), p.462.e1-462.e3

2016

Volltextzugriff (PDF)

HCV and diabetes: towards a ‘Sustained’ glycaemic improvement after treatment with DAAs? – Authors' reply

Clinical microbiology and infection, 2017-05, Vol.23 (5), p.344-344

2017

Volltextzugriff (PDF)

Short-term in vivo modifications of platelet NADPH oxidase 2 (NOX2) and prostaglandin F 2α in HIV-1 patients on abacavir-based therapies

HIV medicine, 2016-11, Vol.17 (10), p.774-777

2016

Volltextzugriff (PDF)

Short‐term in vivo modifications of platelet NADPH oxidase 2 (NOX2) and prostaglandin F2α in HIV‐1 patients on abacavir‐based therapies

HIV medicine, 2016-11, Vol.17 (10), p.774-777

2016

Volltextzugriff (PDF)

Analysis of intracellular human immunodeficiency virus (HIV)-1 drug resistance mutations in multi-failed HIV-1-infected patients treated with a salvage regimen: 72-week follow-up

Clinical microbiology and infection, 2013-07, Vol.19 (7), p.E318-E321

2013

Volltextzugriff (PDF)

HIV and AIDS Programmes in Zimbabwe: Implications for the Health System

ISRN immunology, 2012-01, Vol.2012, p.1-11

2012

Volltextzugriff (PDF)

Detection and quantification of EBV, HHV-6 and CMV DNA in the gastrointestinal tract of HIV-positive patients

Infection, 2014-12, Vol.42 (6), p.1033-1037

2014

Volltextzugriff (PDF)

Long-term evaluation of T-cell subsets and T-cell function after HAART in advanced stage HIV-1 disease

AIDS (London), 1999-07, Vol.13 (10), p.1187-1193

1999

Volltextzugriff (PDF)

Splenic marginal zone lymphoma in a HIV-1 infected patient: evidence favouring a pathogenetic role of HIV-1 itself in the lymphomagenesis

Infection, 2013-02, Vol.41 (1), p.255-258

2013

Volltextzugriff (PDF)

Assessment of thymic output in common variable immunodeficiency patients by evaluation of T cell receptor excision circles

Clinical and experimental immunology, 2002-08, Vol.129 (2), p.346-353

2002

Volltextzugriff (PDF)

Undifferentiated Connective Tissue Disease - An Unsolved Problem: Revision of Literature and Case Studies

International journal of immunopathology and pharmacology, 2010-01, Vol.23 (1), p.271-278

2010

Volltextzugriff (PDF)

Comparison of a Rule-Based Algorithm with a Phenotype-Based Algorithm for the Interpretation of HIV Genotypes in Guiding Salvage Regimens in HIV-Infected Patients by a Randomized Clinical Trial: The Mutations and Salvage Study

Clinical infectious diseases, 2006-05, Vol.42 (10), p.1470-1480

2006

Volltextzugriff (PDF)

Cardiometabolic multimorbidity is associated with a worse Covid-19 prognosis than individual cardiometabolic risk factors: a multicentre retrospective study (CoViDiab II)

Cardiovascular diabetology, 2020-10, Vol.19 (1), p.164-164, Article 164

2020

Volltextzugriff (PDF)

Recovery of hematopoietic activity in bone marrow from human immunodeficiency virus type 1-infected patients during highly active antiretroviral therapy

AIDS research and human retroviruses, 2000-10, Vol.16 (15), p.1471-1479

2000

Volltextzugriff (PDF)

Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial

Journal of antimicrobial chemotherapy, 2018-07, Vol.73 (7), p.1955-1964

2018

Volltextzugriff (PDF)

Recovery of haematopoietic abnormalities in HIV-1 infected patients treated with HAART

AIDS (London), 1999-12, Vol.13 (17), p.2486-2488

1999

Volltextzugriff (PDF)

T-cell homeostasis alteration in HIV-1 infected subjects with low CD4 T-cell count despite undetectable virus load during HAART

AIDS (London), 2006-10, Vol.20 (16), p.2033-2041

2006

Volltextzugriff (PDF)

Short-term in vivo modifications of platelet NADPH oxidase 2 (NOX2) and prostaglandin F sub(2 alpha ) in HIV-1 patients on abacavir-based therapies

HIV medicine, 2016-11, Vol.17 (10), p.774-777

2016

Volltextzugriff (PDF)

Leptin levels in HIV-positive patients treated with HAART

AIDS (London), 1999-12, Vol.13 (17), p.2479-2492

1999

Volltextzugriff (PDF)

Potential benefit of dolutegravir once daily: efficacy and safety

HIV/AIDS (Auckland), 2013-01, Vol.5 (default), p.29-40

2013

Volltextzugriff (PDF)

Correlation between Enzyme-Linked Immunosorbent Assay and Immunofluorescence Assay with Lytic Antigens for Detection of Antibodies to Human Herpesvirus 8

Clinical and Diagnostic Laboratory Immunology, 2001-01, Vol.8 (1), p.203-205

2001

Volltextzugriff (PDF)

Occurrence of Pneumocystis carinii pneumonia in HIV-1-infected patients responding to HAART: Is prophylaxis discontinuation a safe tool?

AIDS (London), 1999-12, Vol.13 (17), p.2488-2489

1999

Volltextzugriff (PDF)

Impact of new DAA therapy on real clinical practice: a multicenter region-wide cohort study

BMC infectious diseases, 2018-05, Vol.18 (1), p.223-223, Article 223

2018

Volltextzugriff (PDF)

1 – 25 von 303

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(276)
Mit Volltextzugriff
(246)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Rapid decline of fasting glucose in HCV diabetic patients treated with direct-acting antiviral agents

HCV and diabetes: towards a ‘Sustained’ glycaemic improvement after treatment with DAAs? – Authors' reply

Short-term in vivo modifications of platelet NADPH oxidase 2 (NOX2) and prostaglandin F 2α in HIV-1 patients on abacavir-based therapies

Short‐term in vivo modifications of platelet NADPH oxidase 2 (NOX2) and prostaglandin F2α in HIV‐1 patients on abacavir‐based therapies

Analysis of intracellular human immunodeficiency virus (HIV)-1 drug resistance mutations in multi-failed HIV-1-infected patients treated with a salvage regimen: 72-week follow-up

HIV and AIDS Programmes in Zimbabwe: Implications for the Health System

Detection and quantification of EBV, HHV-6 and CMV DNA in the gastrointestinal tract of HIV-positive patients

Long-term evaluation of T-cell subsets and T-cell function after HAART in advanced stage HIV-1 disease

Splenic marginal zone lymphoma in a HIV-1 infected patient: evidence favouring a pathogenetic role of HIV-1 itself in the lymphomagenesis

Assessment of thymic output in common variable immunodeficiency patients by evaluation of T cell receptor excision circles

Undifferentiated Connective Tissue Disease - An Unsolved Problem: Revision of Literature and Case Studies

Comparison of a Rule-Based Algorithm with a Phenotype-Based Algorithm for the Interpretation of HIV Genotypes in Guiding Salvage Regimens in HIV-Infected Patients by a Randomized Clinical Trial: The Mutations and Salvage Study

Treatment simplification to atazanavir/ritonavir + lamivudine versus maintenance of atazanavir/ritonavir + two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M)

Cardiometabolic multimorbidity is associated with a worse Covid-19 prognosis than individual cardiometabolic risk factors: a multicentre retrospective study (CoViDiab II)

Recovery of hematopoietic activity in bone marrow from human immunodeficiency virus type 1-infected patients during highly active antiretroviral therapy

Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial

Raltegravir once daily or twice daily in previously untreated patients with HIV-1: a randomised, active-controlled, phase 3 non-inferiority trial

Recovery of haematopoietic abnormalities in HIV-1 infected patients treated with HAART

T-cell homeostasis alteration in HIV-1 infected subjects with low CD4 T-cell count despite undetectable virus load during HAART

Short-term in vivo modifications of platelet NADPH oxidase 2 (NOX2) and prostaglandin F sub(2 alpha ) in HIV-1 patients on abacavir-based therapies

Leptin levels in HIV-positive patients treated with HAART

Potential benefit of dolutegravir once daily: efficacy and safety

Correlation between Enzyme-Linked Immunosorbent Assay and Immunofluorescence Assay with Lytic Antigens for Detection of Antibodies to Human Herpesvirus 8

Occurrence of Pneumocystis carinii pneumonia in HIV-1-infected patients responding to HAART: Is prophylaxis discontinuation a safe tool?

Impact of new DAA therapy on real clinical practice: a multicenter region-wide cohort study

Suchergebnisse filtern